Access cutting-edge transthyretin amyloidosis treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this La Jolla location
Preparing your pre-screening questions…
Access transthyretin amyloidosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related transthyretin amyloidosis treatment provided free
Check if you qualify for this transthyretin amyloidosis clinical trial in La Jolla, CA
No-Cost Study Care
Local to La Jolla
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The MaesTTRo study aims to enroll a global cohort of patients with transthyretin (ATTR) amyloidosis to longitudinally observe the natural course of the disease and describe real-world treatment patterns and outcomes. In addition, information on the effectiveness of ATTR amyloidosis treatments, including eplontersen, which is a ligand-conjugated antisense oligonucleotide gene silencing treatment targeting activity against both the mutant and wild-type TTR protein, will be collected.
Sponsor: AstraZeneca
Yes, this clinical trial (NCT06465810) has an active research site in La Jolla, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for transthyretin amyloidosis treatment options in La Jolla, CA, this clinical trial (NCT06465810) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced transthyretin amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all transthyretin amyloidosis clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in La Jolla — not just this study.
Browse Essential Tremor Trials in La Jolla →